In this era of accelerated drug development, understanding the challenges of time, insight and integration is key to achieving commercial success.
TORONTO (PRWEB)
June 26, 2023
Marketing and commercialization are not individual functions, but rather a cross-functional process. Everyone plays an important part to 1) collectively identify an unmet need; 2) design and develop new treatment approaches that advance the standard of care; and 3) drive awareness of the clinical insights that prove how, why and whom a better treatment approach can benefit.
Three resources that are too often squandered: time, insight and integration.
For deeper discussion into this, an upcoming free webinar titled “The Three Perils of Cross-Functional Drug Commercialization — Time, Insight and Integration” is scheduled for Wednesday, July 12, 2023, at 11 am EDT.
The webinar aims to discuss the often-squandered resources in drug commercialization. The cross-functional process of marketing and commercialization plays a significant role in identifying unmet needs, designing and developing novel treatment approaches and driving awareness of clinical insights. This webinar will provide attendees with the opportunity to explore these critical aspects of successful drug commercialization and their contribution to market success.
The event will feature three prominent speakers: Kipp Kreutzberg, Vice President of Sales and Marketing at Syneos One, Full Service Commercial at Syneos Health; Dr. Raymond A. Huml, Vice President of Medical and Scientific Strategy at Syneos Health, Head of the Rare Disease Consortium and Co-Founder and Executive Sponsor of the Persons with Disabilities Employee Resource Group; and Christopher M. Cashman, an independent Senior Executive in biopharma drug development and commercialization.
“In this era of accelerated drug development, understanding the challenges of time, insight and integration is key to achieving commercial success. We aim to provide a practical overview that will equip biotech companies with the perspective they need to navigate the complex landscape of drug commercialization,” remarked Kreutzberg. “The stakes are high in drug commercialization. Our discussion will provide an in-depth understanding of the risk identification and strategic planning necessary to navigate this complex process through the confluent lens of the investor, board leadership and C-Suite.”
For more information, or to register for this event, visit The Three Perils of Cross-Functional Drug Commercialization — Time, Insight and Integration.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: